Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,809 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03207061 | Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? | unknown | N/A | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT03543215 | Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | unknown | — | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT04251676 | Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis | unknown | — | 200 | National Taiwan University HospitalOTHER | 0 | Feb 11, 2021 | clinicaltrials |
| NCT04747717 | Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer | unknown | N/A | 30 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT04714931 | Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5) | unknown | N/A | 200 | Acibadem UniversityOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT04746300 | imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS(PROMPT) | unknown | — | 400 | Radboud University Medical CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04736108 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 50 | West China HospitalOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT02247323 | Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125(CA125) | unknown | — | 200 | Beni-Suef UniversityOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT02822157 | Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer(CLIO) | unknown | Phase 2 | 160 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04508686 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04577950 | A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer(SENNAN) | unknown | N/A | 120 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT03457805 | Prostatic Artery Embolization in Advanced Prostate Cancer | unknown | N/A | 20 | Dominik AbtOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | unknown | — | 60 | British Columbia Cancer AgencyOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04637022 | 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial | unknown | — | 50 | Catholic University of the Sacred HeartOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT00667888 | A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation | unknown | Phase 3 | 225 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03432780 | Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer(QRT-SOGUG) | unknown | Phase 2 | 134 | Spanish Oncology Genito-Urinary GroupOTHER | 0 | Jan 22, 2021 | clinicaltrials |
| NCT04582552 | The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer(ROMP) | unknown | — | 60 | Xiaoxiang ChenOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04711421 | Using Pedometers for the Assessment and Enhancement of Mobility in Gynaecological and Oncological Patients Following Surgery. | unknown | N/A | 150 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jan 15, 2021 | clinicaltrials |
| NCT02624531 | Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)(SYSUGO-005) | unknown | N/A | 60 | Sun Yat-sen UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT04699344 | A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis | unknown | — | 500 | Qilu Hospital of Shandong UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT04622761 | Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome(CHROME) | unknown | Phase 2 | 120 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT00501761 | Physical Activity After Endometrial Cancer | unknown | — | 326 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04664244 | Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma | unknown | Phase 2 | 43 | Lei LiOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04678791 | Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma | unknown | N/A | 286 | Peking University Third HospitalOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04651738 | Cell-free DNA Methylation for Endometrial Cancer | unknown | N/A | 400 | Lei LiOTHER | 1 | Dec 21, 2020 | clinicaltrials |
| NCT04642833 | Prostate Cancer in Renal Transplants Recipients(RENPRO) | unknown | — | 30 | University of FlorenceOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT01835977 | Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer | unknown | Phase 2 | 106 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Dec 16, 2020 | clinicaltrials |
| NCT02255890 | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device | unknown | — | 361 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT04663412 | Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer | unknown | N/A | 2 | Azienda Ospedaliera per l'Emergenza CanizzaroOTHER | 1 | Dec 11, 2020 | clinicaltrials |
| NCT04661696 | Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. | unknown | Phase 2 | 75 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04651933 | A Training Set for the HRD Model in EOC | unknown | — | 200 | Lei LiOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04651946 | Cell-free DNA Methylation for Epithelial Ovarian Cancer | unknown | Phase 2 | 400 | Lei LiOTHER | 1 | Dec 3, 2020 | clinicaltrials |
| NCT04646954 | DNA Methylation Testing for the Screening of Uterine Cervical Lesion | unknown | Phase 3 | 12,000 | Lei LiOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT00303784 | Prostate Adenocarcinoma TransCutaneous Hormones(PATCH) | unknown | Phase 3 | 2,200 | University College, LondonOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT04376073 | Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer(ANNIE) | unknown | Phase 2 | 40 | Jihong LiuOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT01505075 | Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer(pHART8) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT01953055 | SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)(SATURN) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02031328 | Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer(2STAR) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02911636 | 5 Fractions of Pelvic SABR With Intra Prostatic SABR(5STAR) | unknown | N/A | 30 | Andrew LoblawOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT03961412 | A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women | unknown | Early Phase 1 | 224 | University of Nevada, RenoOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT03307460 | uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness | unknown | Phase 2 | 52 | Rigshospitalet, DenmarkOTHER | 1 | Nov 23, 2020 | clinicaltrials |
| NCT04635956 | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas | unknown | Phase 2 | 20 | Lei LiOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT04632251 | Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer(LPM-012) | unknown | N/A | 56 | Lightpoint Medical LimitedINDUSTRY | 4 | Nov 17, 2020 | clinicaltrials |
| NCT04566952 | Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer(ANLOLA) | unknown | Phase 2 | 68 | Xiaoxiang ChenOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT03628118 | A Research on Hidden Blood Loss in Open Radical Hysterectomy and Pelvic Lymphadenectomy | unknown | — | 105 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Oct 29, 2020 | clinicaltrials |
| NCT03877627 | The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma | unknown | N/A | 60 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 0 | Oct 29, 2020 | clinicaltrials |
| NCT04588090 | A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity. | unknown | N/A | 200 | Chongqing University Cancer HospitalOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT04590625 | Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer | unknown | Phase 2 | 58 | Zhongshan Hospital Xiamen UniversityOTHER | 1 | Oct 19, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Feb 12, 2021source: clinicaltrials